Drug Shortage Report for IRBESARTAN

Last updated on 2020-08-20 History
Report ID 121934
Drug Identification Number 02365197
Brand name IRBESARTAN
Common or Proper name IRBESARTAN
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-08-07
Estimated end date 2020-08-19
Actual end date 2020-08-19
Shortage status Resolved
Updated date 2020-08-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-08-07 English Compare
v2 2020-08-07 French Compare
v3 2020-08-07 English Compare
v4 2020-08-07 French Compare
v5 2020-08-08 English Compare
v6 2020-08-14 English Compare
v7 2020-08-14 French Compare
v8 2020-08-17 English Compare
v9 2020-08-17 French Compare
v10 2020-08-18 English Compare
v11 2020-08-18 French Compare
v12 2020-08-19 English Compare
v13 2020-08-19 French Compare
v14 2020-08-20 English Compare

Showing 1 to 14 of 14